BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$3.92 +0.11 (+2.89%)
At close: Sep 29, 2026 · 4:00 PM EDT

BridgeBio Oncology Therapeutics (BBOT) Total Non-Current Liabilities (2024)

Updated

BridgeBio Oncology Therapeutics (BBOT) posted Total Non-Current Liabilities of $310.87 million for Q1 2024.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Total Non-Current Liabilities (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 BridgeBio Oncology Therapeutics 305.24 Mn -1.07 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 310.87 Mn
API Access

BridgeBio Oncology Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BBOT&period=max&api_key=YOUR_API_KEY